Compare RMCF & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMCF | BNGO |
|---|---|---|
| Founded | 1981 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 12.5M |
| IPO Year | 2024 | 2018 |
| Metric | RMCF | BNGO |
|---|---|---|
| Price | $0.90 | $1.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 4.5M | 148.2K |
| Earning Date | 06-16-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.88 | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,432,352.00 | $12,000,735.00 |
| Revenue This Year | N/A | $14.99 |
| Revenue Next Year | N/A | $34.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.66 | $1.00 |
| 52 Week High | $2.99 | $4.10 |
| Indicator | RMCF | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 51.37 |
| Support Level | $0.84 | $1.14 |
| Resistance Level | $1.19 | $1.35 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 5.69 | 38.46 |
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.